Treatment of Bilateral Endogenous Aspergillus Endophthalmitis with Multiple Intravitreal Voriconazole Injections with Good Visual Outcome
Related Experiment Video
Updated: Oct 4, 2025

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
Inas F Aboobakar1, Sally S Ong1, Akosua Nti1
1Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA.
Abstract:
Endogenous endophthalmitis caused by Aspergillus species tends to be very aggressive, often leading to devastating visual outcomes. Historically, intravitreal amphotericin injections have played a central role in management, but with variable visual outcomes and a risk of toxicity. Limited reports suggest that use of intravitreal voriconazole is a safe and efficacious alternative, though these cases were treated with only few intravitreal injections. Here, we report a case of bilateral endogenous Aspergillus endophthalmitis treated with 8 intravitreal voriconazole injections in the right eye and 11 in the left eye with good best-corrected final visual outcome (20/50 right eye and 20/40 left eye).
Insights
Endogenous Aspergillus endophthalmitis is aggressive. This case study shows multiple intravitreal voriconazole injections effectively treated bilateral Aspergillus endophthalmitis, improving vision.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Mycology
Background:
- Endogenous endophthalmitis caused by Aspergillus species presents a significant challenge due to its aggressive nature and potential for severe vision loss.
- Intravitreal amphotericin B has been a historical treatment, but outcomes are variable and toxicity is a concern.
Observation:
- A case of bilateral endogenous Aspergillus endophthalmitis is presented.
- The patient received multiple intravitreal injections of voriconazole: 8 in the right eye and 11 in the left eye.
Findings:
- Treatment with a high number of intravitreal voriconazole injections resulted in good final visual acuity in both eyes (20/50 OD, 20/40 OS).
- This suggests intravitreal voriconazole can be a safe and effective treatment for severe Aspergillus endophthalmitis, even with repeated administration.
Implications:
- These findings support the expanded use of intravitreal voriconazole for managing aggressive endogenous Aspergillus endophthalmitis.
- Further research into optimal dosing and duration of intravitreal voriconazole therapy is warranted.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

